Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neisseria gonorrhoeae is a Gram-negative, coffee-bean shaped diplococcus bacterium and the causative agent of gonorrhoea, a common sexually transmitted infection. It exhibits several virulence factors including lipooligosaccharide (LOS), fimbriae/pili, outer membrane proteins (PorA/PorB, Protein III), and β-lactamase. The bacterium is capable of rapid antimicrobial resistance development and immune evasion, posing a significant public health threat due to its high prevalence and potential for untreatable infections.
N/A
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neisseria gonorrhoeae (N. gonorrhoeae).